The Current Ratio as of September 2024 (TTM) for Sage Therapeutics, Inc. (SAGE) is 9.95

According to Sage Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 9.95. This represents a change of 0.24% compared to the average of 9.92 of the last 4 quarters.

Sage Therapeutics, Inc. (SAGE) Historical Current Ratio (quarterly & annually)

How has SAGE Current Ratio performed in the past?

The mean historical Current Ratio of Sage Therapeutics, Inc. over the last ten years is 14.67. The current 9.95 Current Ratio has changed 6.68% with respect to the historical average. Over the past ten years (40 quarters), SAGE's Current Ratio was at its highest in in the March 2021 quarter at 33.09. The Current Ratio was at its lowest in in the September 2017 quarter at 4.98.

Sage Therapeutics, Inc. (SAGE) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Sage Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sage Therapeutics, Inc. (SAGE) Average Current Ratio

How has SAGE Current Ratio performed in the past?

The current Current Ratio of Sage Therapeutics, Inc. (SAGE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Sage Therapeutics, Inc. (SAGE) Current Ratio vs. Peers

How is SAGE’s Current Ratio compared to its peers?

Sage Therapeutics, Inc.’s Current Ratio is greater than Apellis Pharmaceuticals, Inc. (5.08), less than Terns Pharmaceuticals, Inc. (21.02), greater than Day One Biopharmaceuticals, Inc. (4.09), greater than Blueprint Medicines Corporation (3.71), less than Cerevel Therapeutics Holdings, Inc. (10.22), greater than Mirati Therapeutics, Inc. (7.54), greater than Amylyx Pharmaceuticals, Inc. (4.66), less than Relay Therapeutics, Inc. (15.64), greater than Stoke Therapeutics, Inc. (6.67), less than Pliant Therapeutics, Inc. (14.47), greater than Black Diamond Therapeutics, Inc. (6.87), greater than Arvinas, Inc. (3.62), greater than Krystal Biotech, Inc. (9.50), greater than Alnylam Pharmaceuticals, Inc. (3.01), greater than Madrigal Pharmaceuticals, Inc. (8.72), greater than Incyte Corporation (1.92), greater than Reata Pharmaceuticals, Inc. (3.21), less than DiaMedica Therapeutics Inc. (17.82), less than Akero Therapeutics, Inc. (24.89), less than Nuvalent, Inc. (17.44), greater than Immunocore Holdings plc (5.17), less than Ventyx Biosciences, Inc. (14.19),

Build a custom stock screener for Sage Therapeutics, Inc. (SAGE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sage Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sage Therapeutics, Inc. (SAGE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sage Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.